EN
抗体药类似物
Research Grade Plozalizumab
All
  • CatalogTD-HW392016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsMLN-1202,anti-CCR2,hu1D9,CAS:1610761-46-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Plozalizumab


Catalog No. TD-HW392016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target CCR2, CC-CKR-2, C-C chemokine receptor type 2, CCR-2, C-C CKR-2, MCP-1-R, CMKBR2, CD192, Monocyte chemoattractant protein 1 receptor
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P41597
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names MLN-1202,anti-CCR2,hu1D9,CAS:1610761-46-0
Background Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research.
Note For research use only. Not for use in clinical or therapeutic applications.